Eight patients with idiopathic myelofibrosis (IMF) were treated with escalating doses (0.5 microgram/day to 4.0 micrograms/day) of 1 alpha(OH)D3 for periods up to 6 months. The treatment did not improve the disease parameters in any of the patients under study. No patient demonstrated a decrease in bone marrow fibrosis as determined by serial procollagen (PC III) serum level analysis. Although 1 alpha(OH)D3 was well tolerated at the administered doses, the therapeutic value of this treatment for IMF requires further evaluation.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
procollagen iii
8
idiopathic myelofibrosis
8
alphaohd3 treatment
4
treatment procollagen
4
iii iii
4
iii studies
4
studies idiopathic
4
myelofibrosis patients
4
patients idiopathic
4
myelofibrosis imf
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!